The ELF Office
Haematology Centre
Royal Devon & Exeter Hospital
Barrack Road
Exeter
EX2 5DW
Charity Number 1154727
exetef
leukaemia
fund
l October 2025
Dear Sirs
This representation letter Is provlded In connectlon with independent examination of the flnancial
statements of the charity for the period ended 31 March 2025, for the purpose of expressing an opinion as
to whether the financial statements are presented fairly, In al I materlal aspects, lor give a true and fa ir
view) in accordance with the applicable financial reportlng framework.
We confirm that the following representations are made on the basls of enquiries of the trustees,
management and staff with relevant knowledge and experience {and, where appropriate, of inspection of
supporting documentation) suff icient to satisfy ourselves that we can properly make each of the following
representations to you:
l. We have fulfi Iled our responsibilitles as trustees under the Charities Act 2011 for preparing
financial statements, in accordance with the applicable financial reporting framework, FRS 102 and
the FRS 102 Charity SORP.
We confirm that in our opinion the flnanclal statements give a true and fair view and in partlcular
that where any additional information must be disclosed in order to give a true and fair view that
Informatlon has In fact been disclosed, We confirm that the selectlon and application of the
accounting pollcles used in the preparation of the financial statements are appropriate, and we
approve these accounts for the period ended 31 March 2025.
2. We confirm that all accounting records have been made available to you for the purpose of the
independent examination, in accordance with your terms of engagement, and that all the
transactions undertaken by the charity have been properly reflected and recorded in the
accounting records. All other records and related information, includi ng minutes of all
Management, trustees, and members, meetings, have been made available to you. We have given
you unrestricted acces5 to persons within the charity in order to obtain evidence and have provided
any additional information that you have requested for the purposes of the Independent
examination.
3. We confirm the charity has satisfactory title to all assets and there are no liens or encumbrances on
the assets, except for those disclosed in the financial statements.
4. We confirm that significant assumptions used by us in making accounting estimates, including
those measured at fair value, are reasonable.
S. We confirm that we have no plans or intentions that may materially alter the carrying value and,
where relevant, the fair value measurements or classification of assets and liabilities reflected in
the financial statements.
Registered CIO 1154727
www.elfcharity.org.uk

6. We confirm that the charity has no liabilities or contingent liabilities other than those disclosed in
the financial statements.
7. We confirm that all known actual or possible litigation and claims whose effects should be
considered when preparing the financial statements have been disclosed to you and accounted for
and disclosed in accordance with the applicable financial reporting framework.
8. We confirm that there have been no events since the balance sheet date which requlre dlsc1051ng
or which would materially affect the amounts in the financial statements, other than those already
disclosed or included i n the financial statements,
9. We confirm that we are aware of the definition of a related party for the purpose of the accounting
framework being applied in the preparation of the accounts, We confirm that there have been no
materia I transactions with related parties.
10. We confirm that the charity neither had, at any tlme during the year, any arrangement, transaction
or agreement to provide credit facillties lincludi n8 advances and credits granted by the charity) for
trustees, nor provided guarantees of any kind on behalf of the trustees.
11. We confirm that the charity has not contracted for any capital expendlture,
12. We confirm that the charity has complled wlth all aspects of contractual agreements that could
have a material effect on the financial statements in the event of non-compliance.
13. We confirm that we are not aware of any possible or actual Instance of non-compliance with those
laws and regulations which provide a legal framework within which the charity conducts its
activities and which a re central to the charitvs a bility to conduct Its activities.
14. We acknowledge our responsibility for the design, implementation and maintenance of internal
controls to prevent and detect fraud.
15. We confirm that there have been no actual or suspected instances of fraud involving trustees,
management or employees who have a significant role In Internal control or that could have a
material effect on the flnanclal statements. We also confirm that we are not aware of any
allegations of fraud by trustees, former trustees, analysts, employees, former employees,
regulators or others.
16. We confirm that, in our opinion, the charit¢s flnancial statements should be prepared on the golng
concern basis on the grounds that current and future sources of funding or support will be more
than adequate for the charity's needs. In reaching this conclusion, we have taken into account all
relevant matters of which we are aware, and have considered a period of at least one year from the
date on which the financial statements will be approved.
17. We confirm that all grants, donation5 and other income, including those subject to special terms or
conditions or received for restricted purposes, have been notified to you. There have been no
breaches of terms or conditions during the period regarding the application of such income.
18. We confirm that in our opinion the effects of unadjusted misstatements are immaterial, both
individually and In aggregate, to the financial statements as a whole.
19. We confirm the following specific representations made to you durlng the course of your
independent examination:.
a. We confirm that funds have been correctly designated as restricted where those funds can
only be lawfully used for a specific charitable purpose5 which are narrower than the
general purposes of the charity.
Registered CIO 1154727
www.elfcharity.org.uk

b. We confirm that all income streams have been reviewed and assessed in terms of VAT
compliance. We also confirm that there are no income streams which are deemed to be
taxable.
20. We acknowledge our legal responsibilities regarding disclosure of information to you as
independent examiners and confirm that:
so far as each trustee 15 aware, there is no relevant Information of which you as independent
examiner5 are unaware,. and
each trustee has taken all the steps that they ought to have taken as a trustee to make
themselves aware of any relevant information and to establish that you are aware of that
information.
Yours faithfull
Signed on be
alf
the
boa
stees
Trustee
Date..........
Registered CIO 1154727
www.elfcharity.org.uk

Charity registsation iiumber. 1154727
Exeter Leukaemia Fund CIO
Annual Report Mt)d Financial Statements
for the Year Ended 31 March 2025

Exeter Leukaemia Fund CIO
Contents (continued)
Reference and Administrative Details
Trustees, Report
2to9
Statement of Trustees, Responsibilities
10
Independent Examiner's Report
Statement of Financial Activities
12to 13
Balance Sheet
14
Notes to the FinanciAI Statemeiits
15tD26

Exeter Leukaemia Fund CIO
Reference and Administrative Details
Chairman
V E S Salomonsen
Trustees
V E 5 Salomonsen
l M Kenny
CFOX
J M Hawkins
Sscann
S R Cooper
D Charlesworth
Senioi. MHn¥gement l Leadership M Soutliwood. Chief Exewtive Officer
Team
ChArity R¢gistratioM Number
11547?7
Principal Office
The ELF Office
Haematology C.entre
Royal Devon & Exeter Hospital
Bai'rack Road
Exeter
EX2 5DW
Independent Examlner
Thompson Jenner LLP
Independent Examinei.
I Collcton Crescent
Exeter
Devon
EX2 4DG
Solicitors
Tozers Solicitors LLP
Broadwalk House
Southernhay West
Barclays Bank PLC
3 Bedford Street
Exeter
Devon
Bgnkers
EXI ILX
Santander UK PLC
53 High Street
Exeter
Devon
EX4 3HE
Page I

Exeter LeukAemia Fund CIO
Trustees, Report
The trustee5 present the annual report together with the financial stateinents of the charity for the yeai. ended 31
March 2025.
Trustees and officers
The truslees and officers setwing during the year since the year end were as follows..
Trustees:
V E S Salomonsei)
l M Kenny
CFOX
J M Hawkins
Ssconn
S R Cooper
D Charl¢sworth (appointed 5 December 20?4)
Chairman..
V E S Salonionsen
Senior Management / Leadership
Teain..
M Southwood, Chief Execulive Officer
S Peacock, Head of Operations and Finance (resigned 21 June 2024)
Chief Executive Officer's Statement
The 2024125 year was a good one for ELF. It remains a pleasure and privilege to lead a great teaiii, and to watch
the charity go froin sli'ength to strcngth.
Across t11e yeai.. we supported more patieiits aiid families tl)an evei. before, travelling across the county to bring
patients lo appointinents, serving Inue17-n¢eded refreshments in the waitiiig room. and increasin¥ oui. wellbeing
service. Additionally, ELF streiigtheiied liiiks with both the NHS team and Citizens Advice, conliiiLiiiig to work
towards a joiiied-up offering.
Our Fellowsliip Pi'ogramme, launched the previous year. contirtiied to provide ￿ndS to liaeniatology staff to
undertake furLher study. As well a5 several Fellowships awarded foi. staft. including nurses and Inedical students
to attend confereii¢es, we were also delighted to offer a larger grant to Jade. an Apprentice Nurse. to complete
her nursing degree.
Our staff team grew in the last qUElrter of the year, as we welcomed a new adiministrator and fundraiser to help
support our growth ambitions. We also welcomed a new Trustee. the first in over two years.
We are proud to be a 511iall, local charity supporting families who we ofteii conie to know very well. Aniong
those we supported across the year was Mr P., who lived alone and faced a termiiial diagnosis. Over the month5
of his treMtmenL our tran5POrt te&m got to know Mr P, and during his journeys to and fi'om hospital, provided
companionship and comfort. Mr P sadly passed away in aU￿￿n 2024, but remeniber¢d ELF in his Will, a
generous acknowledgement ofhow important ELF'S services are to 50 many.
In the final quarter of Éhe year. we signed an Agreement for Lease on a new office premises, a tangible step
towai'ds furthei. growth. Exeter Leukaeinia Fund continues to gl'ow and thrive, and we look forward to
supporting more families.
Molly Southwood Chief Executive Officer
Page 2

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
Objective5 And activities
Policies and objeetives
The objectives of ELF, which are oiitlined in the Constitution of the CIO dated l January 2014 are..
To promote and protect the physical and mental health of people suffering from leukaemia and related
diseases iii the South West of Englaiid (and parLicularly those living iii Devon). and their relatives and
loved ones. through the provision of fiiian¢ial assistance, support, specialist equipmeiit, education and
practical advice. whether to those people or to hospitals, ¢lini¢s and hospices in Devon and
neighbouring ¢ounties.
To advance tPte ediication of the public in all areas relating lo Leulcaemia and relatcd diseases.
In settino objectives and planning for activities, the Trustees aiid senior management have given due
consideratioii to geiieral guidance published by the Charity Commission relating to public benefit. includiiig the
guidance 'Piibli¢ benefit: running a charity (PB2)'.
Vlsion, Mission and Strat¢gy
Vision
We want every patient in Devon diagnosed with blood cancer to have the bcst possible outcome.
Mission Statement
ELF'S niission is to Ci'eate an envii'onment where patients and t17eir famili¢s ure supported through their
leukaemia journey. We want to ensure all blood cancer patients and their families have access to exLellent
support Services, from the poiiit of diagnosis to recovery and beyond.
Strategy
Workiiig with our partners in the NHS, we will design and delivei. 5ector-leading services (o offer direct support
to patients aiid support ihe Haeinatology Centre at the Royal Devon & Exeter Hospital. wliich we helped to
build.
Strategic Objectives
Each y¢ar, tlie Boai-d of Trustees works together with the senior leadership team to agree strategic obje¢tives for
thc coming year, and beyond.
Ow. strategic objectives for the 2024125 year were..
l. Service Dev¢lopinent
.Increase Qu￿ent service delivery
b. Nortji Devon and sites othei. tlian RDE
Wellbeing Services
2. Preparing for futL￿e srowth
a. Marketing aiid brand awareness
b. Income generation, in particular legacies and grants
3. New Homelliub search and planning
4. f501ation Room Refurbishment
Page 3

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
Seryice Development
The table below gives an overview of our performance against our targets.
Servlce
24125 Target
25 Actual
ounselling Referrals
110
111
ransport Total Patients
160
179
upport Group Attendance
Patient Grants
20
241£12,000
mplementary Therapy Patients
ccommodation Patients
150
10
Citizens, Advice Referrals
11 S•rvlce Users
76
Overall. the i)umber of patients we supported iiicreased fi'oni th¢ previous year. W¢ also improved Imany
processes to ensure better d&la capiure and impact reportiiig. We impi'oved our links with our NHS colleagues in
North Devon and subsequently saw an increase in requests for our services from that part ot the county.
We also ints'oduced a sei'ies of support groups. with tlie intention of reaching a broader range of patients than we
did with couiiselling alone. The first series, a patient group, was developed in collaboration with the NHS
haematology teaiii. The second series, ruli indepeiidently by ELF, focused on faniily meinbers aiid supporters.
Preparing for Future Growth
The Board of Trustees recognises that increasing the number of patients and families supported by ELF will
result in increased costs. To put us in tile best possible position lo fuiid that gr0￿h, the charity appointed two
new members of staff in 2024, with a view to increasing philanthropic income by arouiid £150.000 eacli year.
Tlie team also worked to improve ELF'S visibility iii Ihc local community. and oreate a better understanding of
the charity's impact. By focusing on sevei'al high-pix)file 'Charity of Year, initiative, including the Princesshay
Shopping CenÉre iii Exeler. tlie team were able to raise local awareness. Iiivestineiit was also made iii improving
impact communications, iticluding press releases sent to the local niedia and advert15iiig campaigiis around tlig
local area.
Page 4

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
New HomelHub
Tn planning me¢tings, the need for a'hub" where office-based staff could work and hold meetings with potential
supporters, as well as offering a space for service deliveiy. became abundantly clear. With the appointment of
new members of staff, the charity had outgrown our office space and a new hotne was needed.
In December, the Board agreed to move to new premises in Clyst St. Mary. and an Agreement for Lease Mes
sisFned in the final quarter of the year, confirming the charity would move to the new location in June 2025.
IsolAtRon Room Refurbishment
Working with our pai'tnei-s in the NHS we have identified a need to niodernise and I'edecorate the isolatioii
rooms on Yarty Ward. These are Single occupancy treatiMent rooims, typically used by patieiits who ar¢
receiving complex or aggressive treaiments. The rooms have been largely untouched siiice the ward opened in
2006 and are in i)eed of improveni¢n£.
ELF agreed to fund the improvements, and have worked with the relevant teams in the NHS. including Yarty
statT and the Estate5 team to develop a piDposal. By the end ot the financial year. an itemised list of prioriry
work had been developed and initial drawings were coinpleted.
Current Servlce Portfolio
The services Exeter Leukaemia Fund currently offer in relation to the objectives ar¢ a5 follows..
Transport of patients to and from hospital
Counselling to help patieiits and fainilies through the chall¥nges of the illness
Financial support through our Patient Support Grant scheme
Funds to purchase equipment to improve palieiit treatment and support
Accornmodation near the hospital so families can be close to their loved ones
Coinplemeiltary therapies for patients staying on Yarty Ward
Free refreshments to patients ai)d relaiives awaitiiig Day Case appointments
Financial advice througli our partiiership with the CAB
Legal services throu￿7 our paitnei-shtp with Dlinn & Baker
MAin Aetivities undertakeD to further the ChArlty's purposès for the public benellt:
Service5 that ELF provided in 2024125
Transport ServS¢e
The cl￿rity has three dedicated drivers talcing patients to and from their home to attend medical appointments at
the Haematology Centre. fn 202415 the ELF transport team completed 2.202 passenger journeys, with a totsl
distaiice of over 50.000. The increase on the previous year is accounted for by improved systems, as well as
additional driver hours fi'om both paid and volunteer drivers.
The chai'ity has three dedicated drivers taking patients to and from their home to attend medical appointments at
the Haeinatology Centre. In 202415 the ELF transport team completed 2.20?
passenger journeys, with a total
distance of ovcr 50,000. T]ie increase on the previous year is accounted for by improved systems, as well as
additional driver houis from both paid and volunteer drivers.
This service 15 seen by external agencies and p￿tnerS as one of ELF'S Unique Selling Point (USP) services.
Page 5

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
CounselllDg Seryice
We appointed a Counselling Setvices Lead to wn the counselling service, which continu¢s to grow. In ?0?4125
I I I patients were i'eferred to t]ie service. We also offered support to group work led by the NHS, and by ELF.
AccommodAlion
ELF offers financial support to p&tients requiring hotel stays in Exetei. due to their treatment plans. We are
grateful to our partners at Mercure Southgate who offer a discounted rate for ELF patients.
Filing Time
The ELF kiosk, in the Haematology Centre reception, offers snacks and refreshments to patieiils aiid their
supporters. A limited nutiiber of ileins, tncluding liot drinks, fruit, biscuits aiid crisps are offered free of Charge,
though may usei's elecl to ott.er a donation. The café is run by a membei. of ELF staff, and suppoited by
volunteers during periods of annual l¢av¢ or illness.
Complementary Therapies
Aroniaiherapy massage treatnient is provided for pafients stayin8 on Yaty Ward. During the year. the service
offered 119 patient appoinimeiits.
Cltizens Advice Service
During the yeai.. ELF has continued to pi'ovide link5 to the Citizens Advice service foi. patients requiring their
specific help. Across the year, 73 patients w¢r¢ seen. resultiiii? in over £600,000 worth of financial support.
Legal Servlces
ELF offers a free will setvice to patients, patients faiiiilies, volunteers and supporters through a partnership with
local solicitors Dunn and Baker. The service iiicludes tlie wj'iting of a staiidard will aiid is completely fl'ee of
ch8r¥e. The switch fi'om a previous national supplier offers a more localised personal seivi¢e with a local office.
Income Generation
Fundraising
Exeter Leukaemio Fund is now entirely supported by voluntary donations and gifts in Wills. The charity's team
of two full-time fuiidraisers iiicreased during the year, to increase income geiiei'ation potenlial.
We welcomed a new Head of Iiidividual Giving in January 2025, whose I'emit is to focus on gifts from
individual doiiors. We also appointed a Charity Lead Administrator to support administrative work and provide
marketin&> support.
Aci'oss the year we piloted several new initiatives to generate income, including a calendar featuring local
sceiies suggested by patieiits, and a collaboratioii with a local musiL charity to put 01) an eveiiing of opera at a
local stately liome. The tundraising team aimed to diversify iiicome and build on an iiiei-cased awareiiess of tlie
charity's work, following a number of successful charity of the yfdr applications.
Fundraisingi was supported by 108 voliinteers contributing 690 hours of support, covering a l'ange of roles Such
as administt7tion, bucket collections and coordinating collection boxes.
Twsts and tprants remain an area for growth. and we continued to develop case studies in support of poteiitial
grant applications.
We had a strong year for Lega¢y income, and received £149,820 from eight separate legacy donations,
Page 6

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
Retail
Following the decision taken by the Board in ?0?3124 to ¢ease the charity's i'etail function, the remaining shop,
ili Crcditon, ¢losed in June 2024.
Review of activities
Following a review of govemance. policy and procedure in 2023124, the staff and Trustees this year gave their
attention to income generation, lo ensiire the financial sllstainability of the cliarity. This resulted in the
appointinent of the Head of Individual Giving, and an increased focus on promoting legacy giving.
The Board took the decision in December 2024 to uiidertake a review of the patient journey and ELF'S services.
The agreed approach was to apply to work with the University of Exeter MBA prograinme. if possible. The
timeline for this w02'k is to begin the review in June 2025, with a completion date in Septembei. 2025,
The outlook is very positive as we continue to strengthen and improve. We look foiivard to working with staff.
Trustees and partners to increase our service provisioi) to ensure the best possible outcomes for haematology
patients 111 Devon.
Flnanclal revlew
Going concen)
After Imaking appropriate enquiries, the Trustees have a reasonable expectation that rhe c.harity has adequate
resourc¢s to continiie in operational existence for the foreseeable future. Foi. this reason. they continue to adopt
the going concern basi5 in prepariiig the fiiiancial statements. Further details regarding the adoption of the going
conceiii basis Can be found ili tl)e ac¢ountiiig policies.
Reseives policy
Tlie trustees, loiig-teriii strategy is to seek i'eserves excludin8 property to provide financial stability and the
Ineans tor the development of oui. principal activities. We intend to maintain oui. reserves al a level which would
allow an orderly wind down of the charity shoiild that ever need to be considei'ed. lft the coming year we also
intend to use a portion of our rcseives to establish an investmeftt portfolio with the &ini of using iiiterest realised
to contribute towards cliarity rui)ning ¢os15. We intend to use the reserves in the fol lowing manner:
Financial sustainability of the chai'ity
Establishment of an investrnenf portfolio
Community and Hospital Service development
As at the year-end, ELF has total fiinds available of £673,543 (2024: £645,658) and unrestricted funds of
£6?6,979 {2024: £614,523).
Structure) governance 3nd management
Constitution
Exeter Leukaemia Fujid is a registered cliarity, number 1154727, and is coiistitukd under a Charity Commission
Scheme.
The charity is governed by its CJO Deed, dat¢d l January 2014 which was amended 19 January 2021 and under
this deed is constituted as a Charitable Incorporaied Org2ni5ation (CIO). The Trustees meet quarterly. Th¢ CJO
deed stipulates that the Tntst¢es shall comprise iiot more than Leii, nor less than three persons.
The CIO has power to do anything which is ealculaled to further its objects or is condueive or incidental to
doing so. In particular. the CIO has power to..
Page 7

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
l. borrow moiiey and to charge the whole or any part of its property as security for the repayment of the money
borrowed. The CIO must cornply as appropriate with sections 124 and 125 of the Cl]ariÉies Act 2011, if it
wishes Èo mortgage land:
2. buy, take on lease or in exchange. hire or otherwise acquire any property and to maintain and equip it for
sell, lease or otherwise dispose of all or any part of the property belonging to the CIO. In exerGisiiig this
power, the CIO must cornply as appropriaie with sections 117 and 119-123 of the Cliarities Acc 2011 '
4. employ and remunerate such staff as are necessary for cairying out the work of the CIO. Th¢ CIO may
eniploy or remunerate a charity trustee only to the extent that it is permitted to do so by clause 6 (Benefits and
payinentS to charity trustees and connected persons) and provided it ¢omplies with the conditions of that
clause;
5. deposit or invest funds. eniploy a protessioiial fijnd-manager, and arrange for the invescments or other
pi'opety of the CIO to be lield in the name of a noininee, iii the S￿me nianner aiid subje¢t to the same
conditions as the trustees of a trust &re permitted to do by the Triistee Act 2000.
Membership of the CIO
b. Methods of xppointment or eleetlon of Trustees
The management of the Chariry is the responsibility of the Trustees who are elected and co-opted iindei. the
ternis of the Chai'ity Commission Scheine. The Trustees al'e eligible. in comniittee, lo appoint additional trustees
under the terms of the CIO constitution.
Apart from the first chai'ity trustees. every Trustee may be appointed for a muimum term of thi'ee. three-year
temis by a resolution passed at properly convened meetiiigs of the CIO Trustees. In selecting individuals for
appointsnei)t as Trustees, Ilie existing Trustees must have regard to tlie skills, knowledge and experience needed
for the effective administrmtioi) of the CIO.
Policies adopted for the induction and trAlning of Trustees
New li'ustee5 are selected based on the skills and exp¢i'ience, which should coinplemenc those of the existing
Board of Trustees. They meet with existing Trustees and key Inembers of staff to ensure that they feel
comfortable with the organisalion aiid liappy to bccome pai't of the tcain.
The charity Trustees will make available to each new cliarity Trustee. on or before his or her first appointment:
a) a copy of the current vei'sion of this constitution- aiid
b) a copy of tlie CIO'S Latesl Trustees, Annual Report and stateinent of accounts.
As with all staff..
"The Trustees ofELF review $8laries on an annuil basis, nomally December; however, there is no guarantee of
an automatic increase in your pay as a result of any review Employee Handboul(.
Plalls for future perlody
The Ti'ustees will focu5 On the relationship with the RD & E. specifically Yarty Ward and the wider
liaematology service inrluding that in North Devon, in order to provide lielp and support to patients iii the most
meaningful way. This relationship is seen as paramount so that the haematology staff are supported by the
charity and can therefore provide the best care for their patients and 50 that ELF can then provide support in
additioii to this care.
Page 8

Exeter Leukaemia Fund CIO
Trustees, Report (continued)
The Trustees will also encouiage charity staff to undeitske a review of patient services to ensure they are being
managed effectively and are fit for pui'pose and ihe changing iieeds of the patients.
Funds held xs custodia
None
The annu
approved by the irus¢ee5 of the ch&rity on .....
and signed 011 its behalf by:
V F. S Salom
Chairman an
ns
stee
Page 9

Exeter Leukaemia Fund CIO
Statement of Trustees, Responsibilities
The trustees are responsible for preparing the tnistees, report and the fiiianrial statements in accordance with the
United Kingdom Accounting Standards (United Kingdom Generdlly Accepted Accountiiig Practiee) and
applicable law and regulatioiis.
The law applicable Èo charities requires the trustees to prepare ftnaneial statements for each financial yeai. which
give a true and fair view of th¢ state of atTair5 of the chai-ity and of the iiicoming resoui'ces and application of
r¢sour¢es of the charity for that period. Iii preparing these financial statements, the trustees are required to:
select Suitable accounting polieics and then apply thein consistently.
observe the methods and principles in the Charities SORP,
make judgements and estimates that are reasonable and prudeiit-
state whethei. applicable accounting standards have been followed. SLibject to any material departures
disclosed and explained in the financial statements, and
prepare the financial stateiY]ents on the going Concern basis uiiless it is inappropriate to presume that the
chai'ity will ¢ontinu¢ in busiiic55,
Tli¢ trustees are responsible for l<eeping proper accounting recoi'ds that disclose with reasonable a¢ouracy at any
time the fiiiancial position of th¢ chai'ity and enable th¢in to ensui'e that the financial statement5 Comply with the
Charities Act ?01 I, the Charities (Accounts and Reports) Regulations ?008. and the provision5 of the
constitution. Tlie truslees are a150 responsible for safeguardiiig che assets of the charity aiid hence for taking
reas01)able steps for the pi'evention and deiection of fraud and other iri'egularities.
Tlie tiiistees are respon.sible for the maintenance and integi'ity of the corpoi'ate and financial iiiforini¢ tion
included on the charitable coinpany's website. Legislation governing the prepai'ation and disseininalion of
financial statements may differ from legislation in other juri5dicÉions.
the trustees of the chai'ity on l...i• :.W.%-. and signed on its behalf by.,
VESSal
Chairmaii and trustee
Page 10

Exeter Leukaemia Fund CIO
Illdependent Examiner's Report to the trustees of Exeter Leukaemia Fund CIO
I report to the trustees on Iny examination of the aecounts of Exeter Leukacmia Fuiid CIO for the year ended 31
Mairh 2025.
Responsibilities thnd basis of report
As tl)¢ charity twstees of Exeter Leukaemia Fund CIO you are responsible for the preparation of the accounts in
accordance with the requirements of the Charities Act ?0 I l {'the Act,).
I report in respect of my examinatioii of the Exeter Leuk&emia Fund CIO'S accounts carried out under sectioi)
145 of the 201 l Act and in cai'rying oui my examination I have followed all the applicable Dii'ections given by
the Charity Commission under section 145(5)(b) of the Act.
Independent examiner'5 Statement
Since Exeter Leukaemia Fund CIO'S gross intDme exceeded £250.000 your examiner must be A member of a
body listed iii sectioi? 145 of the 201 l Act. I confiiTh tliat l am qualified to undertake the examination because I
am a member of The Association of Chartei'ed Certifi¢d A¢roLintants, which is olle of the listed bodies.
have completed my examinaiion. T confirm tliat no material inatters have come lo my attention in connection
witli die eX￿nInatiOn giviiig me cause to believe t]iat in a11y niateri&l respect..
accounting I'ecords were T]Ot kept in rcspect of Exeter Leiikaemia Fund CIO as requii-ed by Section 130 of
the Act,. or
2. the accounts do not accord with those records. or
3. the accounis do not comply with the accouiiting requirenients ¢oi)cemiiig the fom and content of accounts
Set out in the Cliaritie5 (Accounts and Reports) Regulations 2008 other tlian any requireinent tliat tlie
ccounts give a 'true and fair view, which is not a matter considei'ed as part of an independent
exaininalion.
I have no conccrns aiid have come across no other matters in connection with the exaniinalion to which attention
should be drawn in tliis report in order to ei)able a proper understandii)g of tlie accounts to be reaclied.
Dave Tucker FCCA
Independent Examiner
The Association of Cliartered Certified Accountants
Thompson Jenner LLP
Chartered Accouiltants
I Colletoii Crescent
Exeter
D￿on
EX2 4DG
Date:.....................
Pagell

Exeter Leukaemia Fund CIO
Statement of Financial Activities for the Year Ended 31 March 2025
Uhrestricted
funds
ResÉriet
funds
Total
2025
Note
IDeome and Endowments from:
Donations and legacies
Other tradiiig activities
liivestment iiicome
413,514
47,501
9,580
27,583
441,097
47.501
9,580
Total income
470,595
27.583
498.178
Expenditure on:
Raising ft]nds
Charitable activities
(169.711)
1?88.839)
(169.711)
(300.582)
{11,743)
Total expenditure
Net income
(458.550)
(11,743)
470.293)
12.045
15.840
27,885
Net movement in funds
12.045
15.840
27.885
Reconciliation of fund8
Total funds brought forward
614.523
31,135
645.658
Total funds carried forward
19
626,568
46,975
673,543
The not¢s on pages 15 to 26 forni an inte(yral part of these financial slat¢ments.
Page 12

Exeter Leukaemia Fund CIO
Statement of Financial Activities for the Year Ended 31 March 2025 (continued)
Unrestriettd
fvllds
Restricted
funds
Total
2024
Note
Income and Endowments from:
Donations and l¢gacies
Other tradiiig activities
Investment ii)¢ome
247,133
16?555
9,4?1
32.104
279,237
162,555
9.421
Total income
419.109
32,104
451.213
Expenditure on:
Raisiiig. funds
Charitable activities
{250.527)
241,717)
(250.527)
268.305
(26,5881
Total expe11diture
492,244
26,588)
(518,832)
Net (expenditure)/income
73.135
.5.516
67.619
Net mov¢m¢nt in ￿ndS
(73,135)
5.516
(67.619)
Reconciliation of funds
Total funds brouglit foiward
687,658
25,619
713.277
Total funds cari'ied foiwai'd
19
614,523
31,135
645,658
All of the charity's activities derive from continuiiig operations duriii¥ (lie above two periods.
Tlie ftinds breakdown for ?024 is shown in note 19.
The notes on p&ges 15 to 26 fomi an inte￿.a1 part of these financial statements.
Page 13

Exeter Leukaemia Fund CIO
(Registration number: 1154727)
Balance Sheet as at 31 March 2025
2025
2024
Note
Fixed assets
Tangible assets
13
11,730
17,924
Current assets
Stocks
Debtors
Cash at bank and liand
14
1,954
24,150
659.258
2.627
16
6?5.77?
685.36?
670,874
Creditors: Amounts falling due witbin one year
Net current assets
23,549
43.140
661,813
6?7.734
Net A55ets
673,543
64S,658
Funds of the chArlty:
Resti'icted income thnds
Restricted funds
19
46,975
31,135
Unrestricted income funds
Uni'estricted funds
626,568
614,523
Total funds
19
673.543
645,658
The finaiicial statements on pages 12 10 26 were approved by the trustees, 8iid authorised for i&su¢ on
IAJQ.,.
d sigiied on their b¢half by:
VESSal
Chairman
cn
ee
The notes on pages 15 to 26 forni an intetsral part of these financial statements.
Page 14

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025
I Charsty status
The chai'ity is a Chai'itable Incorporaied Organis&tion r¢gi5tered in England and Wales.
Tjie addr¢ss ofits registered office is:
Tlie ELF Office
Haematology Centre
Royal Devon & Exeter Hospital
Exeter
EX2 .SDW
2 Accounting policies
Statement of eornpliAne¢
The financial stateinents have been pi'epared in accordance with Accounting and Reporting by Charities..
Stateiiient of Recoiniiieiided Pi'actice {applicable to charities pi'eparing tlieir accouiits iii accordance willi tli¢
Financial R¢portingF Standard applicable in the UK and Repiiblic of Ireland (FRS 102)) (issiied in October 2019)
(Charities SORP (FRS I O?)}, the Fiiiaiirial Reportiii¥ Standard applicable in the UK aiid Republic of Ireland
(FRS 102) and the Cliarilies Aci 2011.
Basis of prepRrAtlon
Exeter Leukaeniia Fund CIO nieets the definition of a piiblic benefit eiitity u11d¢r FRS 10? The accounts
(fiiiancial stateinentsl have been pi'epared uiider Ilie historical cost convention witli items I'ecogni5ed at cost or
tr8nsa¢tion value unless otherwise stated in the relevant note(s) to these accounts.
Golng concern
The ti'ustee5 coiisider that tliere are no material uncertaiiities about the charity's ability to Goiitinue as a going
concern.
Intome endowments
Voluntary income includiiig donation5. gifts, leg&cies and ￿zntS that provide core funding or are of a general
nature is recognised wlien the charity has eiititlement to the income, 11 is probable that the incorne will be
received and the amount can be measured with 5ufficieiit reliability.
Donttilons and legacies
Donations al'e re¢o8nised when the charity has been notified in writing of both the aixount and settlement date.
lii the event tliat a donotioii is subject to conditi0115 that require a level of performai)ce by the charity before tlie
charity is entitled to tlie fui)ds, the income is deferred and not recognised ui)til either those conditions are fully
met, or the fulfilment of those conditions is wholly within the Control Df tlie chariry and it is probable that these
coiiditioijs will be fulfilled iii the reporting period.
Legacy gifts are recognised on a case by case basis following the gi'ant of probate when the
administt2torlexecutor for tlie estate has communicated in w-iting both the a]nount and settlement date. Jn the
event tliat the gift is iii the form of at] asset other than cash or a financial asset traded on a recognised stock
exchajige. recoJts ition is subject to the value of the gift beii)g reliably measurable with a degree of reasonable
accuracy and th¢ title to the ass¢t having been transfei'red to th¢ chai'ity.
Pag¢ 15

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025 (continued)
Grants receivuble
Grnnts ar¢ r¢cognised when th¢ charity has an entitlement to the fiinds and any ¢onditions linked to the grdnts
have been met. Where performance conditions are attached to the grant and are yet to be met. th¢ income is
recognised as a liability and included on the balAnce sheei as deferred iiicome to be released.
Deferredinconie
Deferred income represents amounts received foi. future periods and is released to incomiiig resources in the
period for which, it ha5 been received. Such income is oiily deferred when:
The donor specifies that the grant or dor]ation must only be used in future accounting periods; or
The donor has imposed conditi01ls which niusl be met before the Chai'ity has uncoiidilional entitlement.
Gifts iii kind
Gifts in kiiid donated for distributioii are iiicluded at valuation aiid recogiii%ed as iiicome when they are
disti'ibuled to the projects. Gifts doii&ted for resal¢ are in¥luded a5 income wheii they are sold.
Gifl éild
Iiicome tax recovei'able in relation to donations re¢eived under gift aid or deeds of covenant is recognised at the
time of tlie doiiation.
Jnveslmeiil inL'opne
Interest oli fuiids held oli deposit is included when receivable and the amount can be nieasured reliably by the
harity; tjiis is iioi'mally upoii notification nf the intei'esi paid or payable by the bank.Dividends are recognised
once the dividend ha5 been declared and notification has been received of the dividend due.
Expellditure
All expenditui'e is recognised once there is a legal oi. consu￿¢tIve obligation to that expenditure, it is probable
settlement is required aiid the amount can be measiii'ed reliably. All Costs are alloc&ied to the applicable
expeiiditure lieading that agg71'egaÉe similar costs to that category. Whei'e costs cannot be directly atti'ibuted to
particular h¢adiiig5 they have beeii allocated oli a basis Lonsisient witli tlie use of resources, witli ceiitral staft
cost5 allocated on the basis of time Spent. and depi'e¢iation Charges allocated on the portion of the asset's Use.
Other support costs are allocated based on the spread of staff costs.
Raisiiigfiinds
These are costs incurred in atti'acting voluntary inwme. the manageinent of investments and those incurred in
trading activities that raise funds.
Charitable llLtivilies
Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services
for its beneficiaries. It includes both costs tliat can be allocated directly to such activities a]id thos¢ costs of an
indirect i)atlli'e necessary io support them.
SupporÉ costs
Support costs include central functions and have been allocated to activity cost cat¢gories on a basis c017SiSteiit
with tlie use of resources, for example. allocating property costs by floor areas. 01- per capita, staff costs by tl)e
tinie spent and other costs by their usage.
Page 16

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025 (continued)
Gov¢i'nance costs
These incllide the costs attribLltable to the charity's complianc¢ with constiiutional and statutory requirements.
including audil. straiegic manageinent and trustee5 meetings ajid reimbursed expe115es.
Txxation
The charity is considered to pass the tests set out in Paragraph I Schedule 6 of the Finance Act ?010 and
thei'efore it meets the definitioii of a charitable company for UK corporation tax purposes. Accordingly. the
chai'ity is potentially exempt froin taxation in respect of income or capital gains I'eceived within categories
overed by Chapter 3 Part I l of the Coi'poraiion Ttix Act 201 O or Section 256 of the Taxation of Chargeable
Gains Act 1992. to the extent that siich inco1￿¢ or gain5 are applied exclusively to charitable purposes.
Tangible fixed assets
Individual fixed assets costing £ 100.00 or more are initially Itcorded at cost, less any subsequent accumulated
depreciatioii aiid subsequeiit accumulated inipairmeiit losses
Depreei#tioll and amortisxtion
Depitciation is provided on tangible fixcd asset5 so as to wj'ite off the Cost or valuation, less any estimated
residual value, over their expected usefvl eeoiiomic life as follows:
Asset class
Motor vehicles
Fixtures and fittings
Office equipment
Depreeiation method And rate
O % straight line
15 % straight linc
200/D and 33.330/0 slraight line
Stock
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell, after due regard
for obsolete and slow nioviiig stocks. Cosl 15 determiiied using the first-in, first-out (FIF O).
Trade debtors
Trade debtors are aniount5 due from customers for merchandise sold or services performed in che ordinary
coui'se of business.
Trade dcbtors are recognised iiiitially at the tr￿]sactIon price. They are subsequently measured at aJnortis¢d cost
using tlie effective iiiterest method, less provision for impairment. A provision t.or Ilie impairmeni of trade
debtors is established wlien there is objective evidence that the charity will not be abl¢ to rollect all amounts due
according to tlie originMI teiThs of the receivables.
Cash and cash equivBlents
Cash ffnd c&sh equivalents compi'ise cash on hand and call deposits, and other short-term highly liquid
investments that are readily convertiblc to a known amount of cash and are subject to an insignificant i'isk of
change in value.
Page 17

Exeter Leukaemia Fund CIO
Notes to the Flnancial Statements for the Year Ended 31 March 2025 (continued)
Trmde Creditors
Trade creditors are obligations to pay foi. goods oi. services thai have been a¢quii'ed in the ordinary course of
busine55 from suppliers. Accounts payable are classified as current liabilities if the does not have an
unconditional right, at tlie eiid of tlie i'eporting period, to defer settlement of the crediior for at least twelve
months after tlie reporting date. If th¢r¢ is an unconditional right to defer settlement for at least twelve months
after the reporting date, they al'e presented as non-current liabilities.
Trade creditors are recogiii5ed initially at the transaction price and subsequently measured at amortised cost
using the effective interest method.
Fund strueÉure
U11￿striCted incoiiie fjJi)ds are g¢n¢i'al fu17ds that are available for use at the trustees disci'etioii iii ftirthei'ance of
the objectives of the charity.
Restricted income funds are ihose donated for use in a particular area or for specific purpos¢s, the use of which
is restricted to that area or purpose.
Pensions And other post retirement obligations
The charity operates a defiiied contribution pension scheme which is a pension plan under which fixed
coiitribulioiis are paid into a pe115ioiI fuiid and the clidrity has no le¥al oi. constructive obligyatioii to pay ￿l'ther
conti'ibutions even if the fund does llot hold Sufficient assets to pay all employees ¢lie beiiefits relating to
employee service iii tlie ciirrent and prior periods.
Contributions to defined coiitribulion plans are recognised in tlie Statement of Financial Activities when they are
due. If contribution payments exceed the conti'ibiition due foi. service, cli¢ excess is recognised as a prepayment.
FinaNcial instruments
Tlie C.liarity oiily lias financial assets aiid financial l labilities of a kiiid tliut qualify as basic fiiiancial iiis(ruinei)s.
Basic financial insti'iiments are initially re¢ogi)ised at transaction pi'ice and subseqLtently measured at theii.
setilemeiit value with the exceptioii of bank loans which are subsequeiitly measui-ed at aitjortised c05t usinby the
effective inierest metliod.
Page 18

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025 (continued)
3 Income from donation5 and legaeies
Unr¢strlcted
funds
GenerAI
Resfjricted
funds
Total
2025
Total
2024
Donations and lega¢i¢g'
Donations from compaiiies, trusts
and similar proceeds
Legacies
Grants, including Capital grants-
Grants from companies
251,564
149.820
27,583
279.147
149.820
234,818
25,519
12,130
12,130
18,900
413.514
441,097
279.237
Of the above income £413,514 (?024.' £247,133) was unresti'icted and £27,583 {2024.. £32.104) was restricted.
4 Ineome fyom other tradlng aetivities
Unrestrlcted
funds
General
Total
funds
Total
2024
Ti7ding income;
Charity shops
Other fijiidraising
12,475
35.026
12.475
35,026
129.320
33,235
47,501
47,501
162.555
S Investment incom¢
Unrestricted
funds
General
Total
2025
Total
2024
Dividends I'cceivable froin otlier listed investmcnts
Interest receivable on bank deposits
123
9.457
123
9,457
133
9,288
9,580
9,580
9,421
Page 19

0¢ ery Eo
Q¢
- C tn
4 ry4
rn
fn
v) ￿ C

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025 (continued)
Of totsl expenditure £11.743 {?024- £26.588) is restrickd and £458,550 (2024- £492,244) is unrestricted.
7 Analysis of governance and support costs
Governance costs
Unrestricted
funds
General
TotAI
2025
Total
2024
Stsff costs
Wages and salaries
Social security costs
Peiision COSLS
Independent exaininer fees
Examiiialion of the financial statements
Other fees paid to examiiiers
26,366
2.820
667
26,366
37,159
3,787
913
667
1,000
2,200
1,000
2,200
1.000
2,000
33,053
33,053
44.859
8 Net incomingloutgoing r¢sour¢es
Net incomingl(outgoing) resources for the year include,,
2025
2024
ProtiLI(loss) on disposal of tangible fixed assets
Depreciation of fixed assets
60
6.575
147
6,998
9 Trustees remunerAtlon and expenses
No trustee5. nor any persons coiinected with them, have received any itmuneratton from th¢ charity during the
year.
No trustees liave received aiiy reimbursed expenses or aiiy other benefits froin the charity during tlie year.
Page 21

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025 (continued)
10 Staff costs
The aggregate payroll costs weir as follows..
2025
2024
Staff costs durillg the yearweye:
Wages and Salaries
Sorial 5ecui.ity costs
Pension costs
242,873
16.400
5.153
274,464
5,096
264,426
295,632
The monthly average iiumber of persons (including senior managemciit / leadership team) eniployed by tlie
harity dui'ing the year wms as follows:
2025
2024
A verage nuinber of employees
14
14
Coiitributions to the employee pension schemes for the year totalled £5,153 (2024 - £5.096).
Th¢ total employee benefits of the key management personnel of the charity were £59,705 {2024- £83,718).
No employee received emoliiinents of morc than £60,000 during the year
I I Independent exJmin¢r's remuneratlon
2025
2024
Examination of the financial statements
1.000
1,000
Other fees to exAminers
All other services
2,200
,000
12 Taxation
Tile charity is a registered charity and is therefore exempt from tsxation.
Page 22

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025 (continued)
13 Tangible fixed assets
Furniture and
equÈpment
Computer
equipinent
Motorvehicles
Tot91
Cost
At l Api-il 2024
Additions
Disposals
4,482
11,973
23.165
420
(1,312)
39,620
420
1,312)
At 31 March 2025
4,482
11,973
22,273
38,728
DepreciAtion
At l April 2024
Charge for the year
Eliminated on disposals
4,032
268
6.386
2.394
11,278
3,912
(1,272)
21,696
6,574
(1.272
At 31 Mai'cli 2025
4,300
8.780
13.918
26,998
Net book value
At 31 March ?025
182
3,193
8,355
11.730
At 31 March 2024
450
5,587
11,887
17.924
14 Stock
202S
2024
Stocks
1.954
?,627
15 Debtors
2025
2024
Trade debtor5
Prepaymeiits
VAT recoverable
Other debtors
1,026
11,663
2,491
8,970
4,093
8,465
27,352
24,150
42,475
16 Cash cash equivxlent5
2025
2024
Cash on hand
Cash at bank
280
658.978
273
62S,499
659,258
625,772
Page 23

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025 {continued)
17 Creditoi's: amounts falling due within one ye4r
2025
2024
Trade Creditors
Other creditors
Acci'uals
Deferred income
11,197
1,889
9,153
1.310
9.565
1,377
23,549
43,140
2025
2024
Rcsources defetTed in tiie period
Deferred incoine at year end
1,310
1,310
18 Obligatlons under le4se$ and hli'e purehA5e cotttracts
Operating leAse commitments
Total ￿tUre minimum lease payinenls under non-cancellable operating leases are as tollows.,
2025
2024
Other
Withiii one year
Between one and five years
16,983
?.978
38,601
19.961
19.961
58,562
Page 24

Exeter Leukaemia Fund CIO
Notes to the Financial Statements for the Year Ended 31 March 2025 (continued)
19 Funds
Balonce at I
April 2024
Incoming
resources
Resoui'ces
expended
Balance at 31
MAreh 2025
Unrestrlcted fuDds
General
General funds
614,523
470.595
(458.550)
646,568
Restricted fuiids
Chevithorne Family Suite
Counselloi.
Transport
Hospital ftEnd
Paticnt 5UPPOrt (coordinator)
Fellowship
Bi'ai)Ible Ward
Haeinatolo&ry
Total restricted funds
668
7,250
668
7.250
560
27,52
6,537
2,038
?,000
400
1.000
23.388
(440)
(8.508)
(?,000)
8.537
2,038
2,000
1.195
795)
31,135
27.583
11.743)
46,975
Total funds
645,658
498,178
470,293)
673.543
Balaii¢e at I
April 2023
liicoining
resoui'ees
Resoui'ces
txpeiided
BAl#nce at 31
MArch 2024
Unrestrlrted funds
Geiieral
G¢neral funds
687,658
419,109
(492.244)
614,523
Restricted
Chevithorne Family Suite
Counsellor
Tran5POrt
Hospital fund
Patient SLlPPQrt (coordinator)
Fellowsliip
668
668
7,250
10.250
1,000
16,729
1.000
3,125
(3.000)
{ 1,000)
(5.917)
(15,584)
(1.087)
1,830
23.121
12,642
8,537
2,038
TotAI re5tritted fund
25.619
32.104
(26.588)
31.135
Total funds
713,?77
645,658
Page 25

Exeter Leukaemia Fund CIO
Notes to the Flnancial Statements for the Year Ended 31 March 2025 (colltinued)
The specific purposes for which the funds are to be &pplied are as follows-
Chevithorne Family Suite
The i'estricted funds represent amounts received foi- the Chevithorne project. The
project is complete and tlie balwicc Ca￿led forward is to pay for the upkeep of the suite. There has not been any
spend on this project in the year,
Counselling - Grants received to cover counselling staffing costs.
TransPOrt- Income ha5 been received in the period to help support the traiisport service.
Patient Support Coordinator- This fuiid represents amounts raised froin a campaign that was run in order to fuiid
the coordinator position.
Hospltal fund This fund represents any income received which is restrieted to expeiiditure 011 Hospital suppoit.
Bramble Ward-this fund5 restricted to smyths toy and tes¢0 vouchers for Bramble Ward.
Haematology- this funds represent aimounts received foi. tlie Haematology spending.
F¢llowship - This ￿nd represeiits any i17¢0me received which is resu-icted io the fellowship programme.
20 AnAlysis of net Issels b¢twetn funds
Uni'estricted
fuiids
GenerAI
Total fund5 at
31 MArch
Resti'icled
funds
Tangible fixed assets
Current assets
Current liabilities
11,730
638.387
123,549
11.730
685.362
(23.549
46,975
Total net assets
626.568
46,975
673,543
Unrestrleted
funds
CTeneral
Tot&1 funds kt
31 MAreh
2024
Restricted
funds
Tangible fixed assets
Curi'ent assets
Current liabilitie5
17,924
679,739
(43,140)
17,924
670,874
(43,140)
31,135
Total net assets
614,523
31,135
645,658
21 Related party transactlons
There were no related party transactions in the year.
Page 26